United States · 
Who invested in Immunovant?
Immunovant's investors include TCG and TCG Crossover.
United States · Funded startup
Who invested in Immunovant
Funding summaryUpdated 26 Oct 2026
$550Mraised across 1 round since 2025, from 1 source
- Latest round
- Round, $550MDec 2025
- Investors
- 2
The rounds
- Dec 2025
Founders and team
From Immunovant's own website: 6 on the team.
- Becky MerlinaSenior Vice President, Global Head of Quality
- Chedvi Levin-SisterVice President of Finance
- Christine BlodgettSenior Vice President of Human Resources
- Imara Charles PhDVice President, Global Supply Chain
- Michael MillerVice President, Information Technology and Facilities
- Tiago GirãoChief Financial Officer
Everyone who backed them
Missing a round, or an investor who was in one? Tell us.
Also claim to have backed them
This firm lists Immunovant as a portfolio company on their own website, but no report of a round names it. They are the firms' own claims, kept apart from the rounds above.
Quick answers about Immunovant
How much has Immunovant raised?
Immunovant has raised $550M across 1 round since 2025.
When did Immunovant last raise?
Immunovant's most recent round was an Undisclosed round of $550M in Dec 2025.
What was Immunovant's biggest round?
Its most recent round, $550M in Dec 2025, is also its largest on record.
Who backed Immunovant first?
Immunovant's first round on record, in Dec 2025, was backed by TCG and TCG Crossover.
What stage is Immunovant at?
Immunovant's latest named round is an Undisclosed round, in Dec 2025.
Where is Immunovant based?
Immunovant is based in the United States.
Companies like Immunovant
In the same sector, and raised in the last eighteen months.
Find investors like these
Search every investor by what they have actually funded, then narrow to your stage and market. Free.